Clinical Trial Update: Co-administration of CART22-65s and huCART19 for B-ALL [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase 1/2 clinical trial update on co-administering CART22-65s and huCART19 for B-cell acute lymphoblastic leukemia and B-lineage lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• B-lineage Lymphoblastic Lymphoma

Drugs mentioned

• CART22-65s
• huCART19

Snippet

Sponsor: Stephan Grupp MD PhD | Conditions: B-cell Acute Lymphoblastic Leukemia, B Lineage Lymphoblastic Lymphoma | Phase 1, Phase 2 | Status: RECRUITING